Clinical Trials Browser

INDUSTRY × Blast Crisis × STA 9090 × Clear all

NCT00964873 2014-09-18

A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Blast Crisis, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma